Loading…
Lipocine Inc. is projected to rise to $2.88 by 2027, a +26% move from its current price of $2.28. LPCN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.21 | $2.28 | $2.35 | -0.02% |
| May 30 | $2.19 | $2.28 | $2.37 | -0.04% |
| May 31 | $2.17 | $2.28 | $2.40 | -0.06% |
| Jun 1 | $2.15 | $2.28 | $2.41 | -0.09% |
| Jun 2 | $2.13 | $2.28 | $2.43 | -0.11% |
| Jun 3 | $2.12 | $2.28 | $2.45 | -0.13% |
| Jun 4 | $2.11 | $2.28 | $2.46 | -0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.11 | $2.28 | $2.46 | -0.15% |
| Week 2 | $2.04 | $2.27 | $2.53 | -0.30% |
| Week 3 | $1.99 | $2.27 | $2.59 | -0.45% |
| Week 4 | $1.94 | $2.27 | $2.64 | -0.60% |
| Week 5 | $1.90 | $2.26 | $2.69 | -0.75% |
| Week 6 | $1.87 | $2.26 | $2.73 | -0.90% |
| Week 7 | $1.84 | $2.26 | $2.77 | -1.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lipocine Inc. is a clinical-stage biopharmaceutical company that engages in the research and development for the delivery of drugs using its proprietary delivery technology.
The company focuses on neurological and psychiatric central nervous system disorders, liver disease, and hormone supplementation in the United States. Lipocine was founded in 1997 and is headquartered in Salt Lake City, Utah. It has a portfolio that includes TLANDO, an oral testosterone replacement therapy, and a range of candidates such as LPCN 1154 (BRLIZIO), LPCN 1148, LPCN 1107, LPCN 1144, LPCN 2401, LPCN 2201, LPCN 2203, and LPCN 2101.
The company collaborates with Verity Pharmaceuticals, Inc. to develop and commercialize TLANDO.
Lipocine Inc. (LPCN) is a healthcare stock currently trading at $2.26 per share, with a market cap of $18.63M and a rank of 4974.
The 30-day technical picture shows a NEUTRAL sentiment, with RSI14 at 30, and moving averages near the price: SMA50 at $3.77 and SMA200 at $4.75. The 30-day price range runs from $1.84 to $2.77, with a support level at $2.20 and a resistance at $2.56.
The forecast base suggests a bullish longer-term trajectory, with average prices rising through 2050 and a max price footprint well above today’s levels. The 2026 average is $2.26, and the 2050 average is $15.57, with a max of $30.23, indicating meaningful upside potential over the horizon.
A major floor 14.9% below — a decisive break under it would weaken the trend.
The nearest floor, 3.5% below — buyers have tended to step in here.
The nearest ceiling, 12.3% above — a clean break opens room to run.
A major ceiling 388.2% above — clearing it would confirm fresh momentum.
Key LPCN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LPCN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.25 | Buy | $2.26 | Buy |
| MA 10 | $2.26 | Buy | $2.27 | Buy |
| MA 20 | $2.30 | Sell | $2.41 | Sell |
| MA 50 | $3.57 | Sell | $3.53 | Sell |
| MA 100 | $6.28 | Sell | $4.53 | Sell |
| MA 200 | $4.74 | Sell | $4.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.85 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -26.80 | Neutral |
| Williams %R (14) | -57.89 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | -3.80 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 42.11 | Neutral |
| TRIX (15) | -2.02 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 46.09 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 2.26 | Buy |
| ADX (14) | 35.05 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 30, indicating oversold conditions, while the SMA50 is $3.77 and the SMA200 is $4.75.
Key support is at $2.20 and resistance at $2.56, with a 30-day range of $1.84 to $2.77.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.94 | $2.28 | $3.12 | 0% | Neutral | |
| $2.27 | $2.88 | $3.88 | +26% | Bullish | |
| $2.51 | $3.28 | $4.59 | +44% | Bullish | |
| $2.74 | $3.67 | $5.29 | +61% | Bullish | |
| $2.59 | $3.55 | $5.25 | +56% | Bullish | |
| $2.72 | $3.79 | $5.73 | +66% | Bullish | |
| $2.85 | $4.06 | $6.26 | +78% | Bullish | |
| $2.90 | $4.20 | $6.59 | +84% | Bullish | |
| $3.72 | $5.47 | $8.73 | +140% | Bullish | |
| $4.04 | $6.04 | $9.78 | +165% | Bullish | |
| $4.98 | $8.01 | $13.83 | +251% | Bullish | |
| $7.89 | $14.40 | $27.31 | +532% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.94 | $2.28 | $2.68 | +0.00% |
| June 2026 | $1.90 | $2.23 | $2.69 | -2.03% |
| July 2026 | $1.88 | $2.24 | $2.73 | +0.08% |
| August 2026 | $1.94 | $2.32 | $2.87 | +3.74% |
| September 2026 | $1.92 | $2.31 | $2.88 | -0.41% |
| October 2026 | $1.87 | $2.26 | $2.84 | -2.05% |
| November 2026 | $1.93 | $2.35 | $2.97 | +3.66% |
| December 2026 | $2.01 | $2.45 | $3.12 | +4.34% |
Click any year to see its month-by-month LPCN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LPCN could reach as high as $3.12, with a base case around $2.28 and support toward $1.94 — roughly 0% from $2.28. Price action looks broadly range-bound.
Expect LPCN to range from $2.27 to $3.88 through 2027. The $2.88 average target implies a +26% move from current prices. That is up +26% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The LPCN price prediction for 2028 points to an average of $3.28 (low $2.51, high $4.59) — a potential gain of +44% on today's $2.28. Momentum favours further upside here.
In 2029, LPCN is projected to trade between $2.74 and $5.29, averaging $3.67 — a potential gain of +61% from today's $2.28. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Lipocine Inc.'s 2030 outlook centres on $3.55, within a $2.59 to $5.25 range. That is -3% versus the projected 2029 average. That marks a +56% change versus current levels. Momentum favours further upside here.
By 2031, LPCN could reach as high as $5.73, with a base case around $3.79 and support toward $2.72 — roughly +66% from $2.28. Buyers look set to stay in control over this stretch.
Expect LPCN to range from $2.85 to $6.26 through 2032. The $4.06 average target implies a +78% move from current prices. That is up +7% on the projected 2031 average. Momentum favours further upside here.
The LPCN price prediction for 2033 points to an average of $4.20 (low $2.90, high $6.59) — a potential gain of +84% on today's $2.28. Buyers look set to stay in control over this stretch.
In 2034, LPCN is projected to trade between $3.72 and $8.73, averaging $5.47 — a potential gain of +140% from today's $2.28. That is up +30% on the projected 2033 average. Momentum favours further upside here.
Lipocine Inc.'s 2035 outlook centres on $6.04, within a $4.04 to $9.78 range. That is up +10% on the projected 2034 average. That marks a +165% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, LPCN could reach as high as $13.83, with a base case around $8.01 and support toward $4.98 — roughly +251% from $2.28. Momentum favours further upside here.
Expect LPCN to range from $7.89 to $27.31 through 2050. The $14.40 average target implies a +532% move from current prices. That is up +80% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in LPCN today (≈ 438.596491 LPCN) could be worth
$6,317.68
+$5,317.68 (+532%) by 2050 · US Dollar
Based on the average projected LPCN price of $14.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LPCNwould be worth at today's price.
$1,000 invested in LPCN on May 27, 2025 (≈ 284.090911 LPCN) would be worth
$647.73
-$352.27 (-35.2%) today · 0.65× · US Dollar
Based on a LPCN entry price of $3.52 vs. today's $2.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.24 | $1,017.86 | +1.8% |
| 1 month ago | $2.37 | $962.03 | -3.8% |
| 3 months ago | $10 | $228 | -77.2% |
| 6 months ago | $3.44 | $662.79 | -33.7% |
| 1 year ago | $3.52 | $647.73 | -35.2% |
| All time (5.0y) ago | $20.74 | $109.93 | -89.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LPCN forecast.
Our base-case forecast reaches $4.60 around 2034.
Implied market cap at $4.60: $37.92M
The multi-year forecast shows a bullish trend developing after 2026. In 2026, the average price is $2.26 with a 0% ROI and neutral sentiment. From 2027 onward, the outlook turns more positive: 2027 average $2.93 with 29.8% ROI, 2028 average $3.37 with 49.1% ROI, 2029 average $3.77 with 67% ROI, and 2030 average $3.65 with 61.3% ROI.
Continuing, 2031 average $3.94 with 74.3% ROI; 2032 average $4.22 with 86.5% ROI; 2033 average $4.40 with 94.8% ROI. The forecast then shows 2034 average $5.86 with 159.4% ROI and 2035 average $6.42 with 184.1% ROI.
Further out, 2040 average is $8.73 with 286.4% ROI and 2050 average is $15.57 with 588.8% ROI. These figures reflect bullish sentiment over the extended horizon, though they remain estimates and are not guarantees. Key risks include the inherent uncertainty of future market movements and the fact that forecasts can change with new information.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $3.65 per share with an estimated ROI of 61.3%.
The forecast indicates bullish sentiment from 2027 onward, with average prices rising to $2.93 in 2027, $15.57 on average by 2050, and ROI up to 588.8%.
Yes. The 2035 max is $10.59, with the 2035 average at $6.42.
Current price is $2.26 and market cap is $18.63M.
The 30-day range is $1.84 to $2.77.
Lipocine Inc. Community Discussion
0Share your Lipocine Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.